Private Advisor Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Private Advisor Group's CRL Position: Q3 2026 in Review
Private Advisor Group opened a new position in Charles River Laboratories (CRL) in Q3 2026: 5,752 shares worth $1.7M. The stake represents 0.01% of the portfolio and ranks #1309 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in CRL as recently as Q3 2024.
Private Advisor Group first reported a position in CRL in Q2 2014 and has held it in 16 quarters since. The position peaked at $6.99M in Q3 2021. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Private Advisor Group held 5,752 shares of Charles River Laboratories worth $1.7M as of Q3 2026.
- Charles River Laboratories was a new Private Advisor Group position in Q3 2026.
- Charles River Laboratories made up 0.01% of Private Advisor Group's portfolio in Q3 2026, its #1309 holding.
- Private Advisor Group first reported a position in Charles River Laboratories in Q2 2014 and has held it in 16 quarters since.
- Private Advisor Group's Charles River Laboratories position peaked at $6.99M in Q3 2021.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.